Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,216) with videos related to
Page
of 122
Sort By:
The Journal of Biological Chemistry
|
April 15, 2006
Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function
Youmei Xie, Stephen M Massa, Sonya E Ensslen-Craig, et al.
Brachytherapy
|
September 18, 2023
Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience
Tugce Kutuk, Ranjini Tolakanahalli, Vibha Chaswal, et al.
Neuro-Oncology
|
March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 6, 2022
Dedicated isotropic 3-D T1 SPACE sequence imaging for radiosurgery planning improves brain metastases detection and reduces the risk of intracranial relapse
Tugce Kutuk, Kevin J Abrams, Martin C Tom, et al.
Neuro-Oncology Practice
|
November 15, 2021
Impact of MRI timing on tumor volume and anatomic displacement for brain metastases undergoing stereotactic radiosurgery
Tugce Kutuk, Ranjini Tolakanahalli, Andre Williams, et al.
Neuro-Oncology
|
January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)
Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227
Jon Glass, Minhee Won, Christopher J Schultz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 30, 2025
Importance of 3D-TSE imaging for patients with brain metastasis treated with SRS alone
Eyub Y Akdemir, Joseph DiStefano, Kevin J Abrams, et al.
Neuro-Oncology
|
July 9, 2026
Comprehensive Performance Testing and External Validation of an AI Algorithm to Detect and Segment Brain Metastases
Rupesh Kotecha, Eyub Y Akdemir, Naseem Ud Din, et al.
Journal of Neuro-Oncology
|
April 28, 2011
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial
Derek R McHaffie, Pierre Chabot, Anne Dagnault, et al.
Page
of 122
Search research articles
Search
Showing results (1001-1010 of 1,216) with videos related to
Sort By:
Page
of 122
The Journal of Biological Chemistry
|
April 15, 2006
Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function
Youmei Xie, Stephen M Massa, Sonya E Ensslen-Craig, et al.
Brachytherapy
|
September 18, 2023
Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience
Tugce Kutuk, Ranjini Tolakanahalli, Vibha Chaswal, et al.
Neuro-Oncology
|
March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 6, 2022
Dedicated isotropic 3-D T1 SPACE sequence imaging for radiosurgery planning improves brain metastases detection and reduces the risk of intracranial relapse
Tugce Kutuk, Kevin J Abrams, Martin C Tom, et al.
Neuro-Oncology Practice
|
November 15, 2021
Impact of MRI timing on tumor volume and anatomic displacement for brain metastases undergoing stereotactic radiosurgery
Tugce Kutuk, Ranjini Tolakanahalli, Andre Williams, et al.
Neuro-Oncology
|
January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)
Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227
Jon Glass, Minhee Won, Christopher J Schultz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 30, 2025
Importance of 3D-TSE imaging for patients with brain metastasis treated with SRS alone
Eyub Y Akdemir, Joseph DiStefano, Kevin J Abrams, et al.
Neuro-Oncology
|
July 9, 2026
Comprehensive Performance Testing and External Validation of an AI Algorithm to Detect and Segment Brain Metastases
Rupesh Kotecha, Eyub Y Akdemir, Naseem Ud Din, et al.
Journal of Neuro-Oncology
|
April 28, 2011
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial
Derek R McHaffie, Pierre Chabot, Anne Dagnault, et al.
Page
of 122